Shorts

0:57
FDA Approval on the Horizon for Anito-cel in Multiple Myeloma
19 hours ago
by
Matthew J. Frigault, MD, MS

1:00
Trispecifics Take T-Cell–Engaging Therapy a Step Further
5 days ago
by
Krish Patel, MD

0:37
Are KRAS Mutations More Common Than We Think?
5 days ago
by
Benjamin Herzberg, MD

0:15
2026 IMS Annual Meeting Highlights Across Myeloma
6 days ago

0:54
ASTRO 2026 Preview with Dr Raj Singh
10 days ago
by
Raj Singh, MD

0:35
Changing Treatment Paradigms in ROS1+ Lung Cancer
12 days ago
by
Jorge Nieva, MD

0:53
Why Community Cancer Centers Must Adapt to New Therapies
12 days ago
by
Andrew Dalovisio, MD

0:55
Why Radiation Therapy Hits a Wall
13 days ago
by
David DiBardino, MD

0:42
T-Cell Therapies Push Blood Cancer Treatment Forward
14 days ago
by
Krish Patel, MD

1:37
How Etentamig Stands Out From Other BCMA Bispecifics
17 days ago
by
Peter Voorhees, MD

0:51
Why Do Promising Cancer Drugs Fail in Phase 3?
18 days ago
by
David DiBardino, MD

0:31
Your Wednesday Oncology Wrap-Up - September 16
18 days ago
by
Sabrina Serani

0:45
Unlocking HER2 Beyond Breast Cancer
20 days ago
by
Aditya Shreenivas, MD, MS

0:39
MSOs: A Support System for Physicians
21 days ago
by
Marcus Neubauer, MD

0:46
How AI Could Take the Guesswork Out of Payer Policies
22 days ago
by
Marcus Neubauer, MD

0:31
Why No Oncologist Is Immune to Burnout
23 days ago
by
Marcus Neubauer, MD

0:31
The Truth About Clinical Trial Enrollment
24 days ago
by
Noelle Gillette Cloven, MD

0:34
Tackling the Health Care Interoperability Problem
25 days ago
by
Marcus Neubauer, MD

0:31
The "Holy Grail" of Lung Cancer Surgery?
a month ago
by
Gavin M. Wright, MBBS, FRACS, PhD

0:42
Why Local Cancer Care Access is a Life-or-Death Issue
a month ago
by
Ryan Funk, MD

0:35
The EMR, AI, and the Fight Against Physician Burnout
a month ago
by
Marcus Neubauer, MD

0:43
Doing More With Less: The New Lung Surgery Challenge
a month ago
by
Gavin M. Wright, MBBS, FRACS, PhD

1:12
Upcoming Trials Could Bring New Drug Classes into Prostate Cancer
a month ago
by
Manojkumar Bupathi, MD, MS

0:35
Why Brain Cancer Treatment Feels Like a Rigged Marathon
a month ago
by
Clark Chen, MD, PhD

0:26
Your Wednesday Wrap-Up - September 2
a month ago
by
Sabrina Serani

0:25
The Future of Lymphoma Care Is Moving Forward With Science
a month ago
by
Krish Patel, MD

0:57
Why Cervical Cancer Screening Shouldn't Stop at 65
a month ago
by
Noelle Gillette Cloven, MD

0:39
Recognizing Emotional Exhaustion in Burned-Out Colleagues
a month ago
by
Marcus Neubauer, MD

1:10
Personalizing Therapy After Iberdomide Approval in Myeloma
a month ago
by
Surbhi Sidana, MD

0:44
Why Oncology Needs Integrated AI Solutions
a month ago
by
Shaalan Beg, MD, MBA, FASCO
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Fast Track Designation to TRE-515 for KRAS G12C NSCLC
2
Pirtobrutinib Gains FDA Approval for Frontline CLL/SLL in Select Patients
3
NDA Submission Initiated for Zipalertinib Combo in EGFR Exon 20+ NSCLC
4
Ubamatamab Shows Durable Responses in Low-Grade Serous Ovarian Cancer
5
